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Summary.-The surviving fraction (SF) of Chinese hamster cells and HeLa cells
after treatment with a range of Adriamycin concentrations and exposure times was
determined. The cytostatic effect was proportional to the product of extracellular
drug concentration (c) and exposure time (t) according to the equation: SF=e-ktc.
By determining the intracellular drug concentration at various exposures, it could
be shown that absorbed dose is not proportional to exposure dose.
ADRIAMYCIN is a potent drug in a
variety of neoplastic diseases (Carter,
1975). Although a number of empirical
dosage schedules are used in the treatment
with Adriamycin (Carter et al., 1972), there
is controversy about optimum schedule
and dosage.
Benjamin et al. (1974) correlating clini-
cal and pharmacological observations pro-
posed the intermittent single high-dose
application of Adriamycin, suggesting
that its effectiveness appeared to be re-
lated to schedule, rather than dose.
Treatment of leukaemia L1210 in the
early stages seemed to have no definite
schedule dependency (Goldin & Johnson,
1975). The clinical studies of Creasy et al.
(1976) suggested that Adriamycin given at
short intervals caused greater toxicity
than widely spaced doses. Pacciarini
et al. (1978) presented experimental data
demonstrating the superiority of the
repeated schedule over the single high-
dose treatment. Although there was simi-
lar anti-tumour activity, survival in-
creased and drug concentration was
markedly lower in the heart than in the
closely spaced schedule.
Skipper et al. (1970) studied optimal
dose schedules for the treatment of L1210
leukaemia. They allotted all the cytostatic
agents to 3 different tentative classes and
showed that each class had a different
optimal schedule. Daunomycin, which in
its action is comparable to Adriamycin
(Di Marco, 1975) belonged to the class of
cycle-phase nonspecific drugs all of which
over a wide range of administered dose
have a concentration-dependent rate of
cell kill. For these agents, he assumed the
effect to be a function of the product of
concentration and time. In the present
study we will describe experiments on the
dependence of cell survival of 2 different
cell lines and Adriamycin concentration
and exposure time. These studies are pre-
liminary to in vivo experiments to be
published elsewhere.
MATERIALS AND METHODS
Cell cultures.-Experiments were carried
out with the following cell lines: B14F28
Chinese hamster cells, a lung fibroblast line
(Born 1974) with an average cell-cycle time
of 11-14 h and HeLa S3 cells, supplied by
Flow Laboratories, Irvine, Scotland, and
adapted to our culture conditions (mean cell-
cycle time 24 h). Monolayer cultures of both
cell lines were cultured in Eagle's minimum
essential medium (MEM) supplemented with
10% calfserum, 0 01% neomycin and0.035%
NaHCO3. They were kept in a humidified
CO2 incubator at pH 7-2 and 37°C (Eichholtz
& Trott, 1980).CYTOSTATIC EFFECT OF ADRIAMYCIN IN VITRO
Drug exposure.-Adriamycin (Farmitalia)
was dissolved in distilled water and, if neces-
sary, was kept at - 18°C for up to one week
without loss ofactivity.
Exponentially growing cells were sub-
cultured and appropriately diluted. Four h
after seeding Adriamycin, diluted in Hanks'
solution, was added to the medium to give
the desired final concentration andthe culture
vessels returned to the incubator. Exposure
was finished by removing the medium, rinsing
twice with pre-warmed Hanks' solution and
adding fresh medium.
Cell survival.-After incubation for 8 days
(Chinese hamster cells) or 14 days (HeLa
cells), the medium was discarded and cells
were stained with methylene blue; colonies
containing more than 50 cells were counted,
and- the ratio of the mean colony yield of
treated to untreated cells, i.e. the surviving
fraction (SF), was calculated. All experiments
were carried out with 4 replicate bottles and
repeated at least 3 times. Experimental data
were accepted ifthe colony-forming efficiency
of the untreated cells was higher than 35%
and if x2 of all replicates was within 95%
probability.
Intracellular drug concentration.-The in-
tracellular concentration of Adriamycin was
determined according to the method of
Schwartz (1973), using a Zeiss Fluorimeter.
At the end of Adriamycin exposure, the cells
were cooled immediately to 4°C, centrifuged,
washed with Hanks' solution and centrifuged
again. The cell sediment was resuspended in
1 ml MEM and added to 0-2 ml AgNO3
(33% w/v). After vigorous shaking for 10
min, the cells were extracted with 3-0 ml
iso-amyl alcohol, shaken again for 10 min
andthencentrifuged (1000gfor5minat20°C).
The fluorescence intensity of the organic
phase was then measured at a wavelength of
585 nm, using an activation wavelength of
483 nm. The readings were compared to a
calibration curve of graded concentrations of
Adriamycin in MEM.
RESULTS
Cell survival as a function of Adriamycin
concentration in the medium
The surviving fraction of exponentially
growing cells was determined after a fixed
exposure time (30, 60, 120 or 240 min) to




Adriamycin on the surviving fraction of
Chinese hamster cells at constant exposure
times. Solid line: linear regression, calcula-
ted with all logarithmically transformed
data points for one fixed time. Dotted lines:
regressions derived from a global least-
squares fit of all logarithmically trans-
formed data according to equation SF=
e-ktc: -0- 30 min; -*- 60 min;
- D- 120 min; Each point represents the
mean ( ± s.d.) surviving fraction of at least
10 dishes ofat least 3 different experiments.
Figs 1 and 2 show the survival curves of
Chinese hamster and HeLa cells respec-
tively (solid line). Each point represents
the mean of all experimental values with
the standard deviation.
FIG. 2.-Corresponding data to Fig. 1 for
response of HeLa cells to Adriamycin with
the addition of240 min exposure times (V).
@ 30 min; O 60 min; * 120 min.
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The linear-regressions were calculated
with all logarithmically transformed data
points of every set of at least 3 experi-
ments with a fixed t (r2 >0.90). In the
concentration range tested the survival
curves of both cell lines are exponential
and extrapolate back to 100% survival.
The steepne'ss of the curve can be charac-
terized bv Co, i.e. the drug concentration
reducing the surviving fraction to 0-37 at
a given exposure time. (To avoid con-
fusion with the concept of dose, which is
theproduct of c and t, the commonly used
term Do was replaced by the respective
abbreviations Co and T,, with the suffix.)
For Chinese hamster cells Co is 0-46 .ug/ml
for I h exposure; for HeLa cells it is 0-35
pg/ml.
A separate set of experiments tested
whether killed cells after treatment with
high concentrations of Adriamycin (SF
<0-005) release biologically active drug
and tbus displace the survival curves
downwards. After washing the treated
cells as usual, untreated cells were added
which, after incubation for 7 days,
yielded the control plating efficiency.
Cell 8urvival a,3 afunction of expasure time
toAdriamycin
Figs 3 and 4 show the SFs of Chinese
hamster and HeLa cells at fixed drug con-
centrations (0-1, 0-5 and 1-0 pg/ml) and
varying exposure times. Each point repre-
sents the mean of all experimental values
at any given concentration with the
standard deviation. The linearregressions,
calculated with all logarithmically trans-
formed data points of every set of at least
3 experiments with a fixed c (r2 > 0.go),
have no shoulder in Chinese hamster cells
and only a small shoulder in HeLa cells,
with an extrapolation number < 2. They
can be characterized by a T,,,, i.e. an
exposure time necessary to reduce the SF
to 0-37, of 20-4 min and 19 min respec-
tively at a drug concentration of I ttg/ml.
The intracellular concentration of
Adriamycin in 2 x 106 Chinese hamster
cells was measured fluorimetrically after
exposure toincreasingdrug concentrations
to. IILWANA-.
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Fic.. 3.-Theeffect ofvariousexposuretimesto
Adriamycin on the surviving fraction of
Chinese hamster cells at constant drug
concentrations. Solid lines: linear regres-
sion, calculated with all logarithmically
transformed data points for one fixed con-
centration. Dotted lines: curves derived
from a global least-squares fit of all
logarithmically transformed dataaccording
to equation SF=e-ktc -0- 0-1 'Ug/Mj;
-0 0-5 )ug/ml; -F.- 1-0 .ug. Eacti
pointrepresents the mean ( ± s.d.) surviving
fraction of at least 10 dishes of at least
3 different experiments.
FIG. 4.-Corresponding data to Fig. 3 for
response of HeLa cells to Adriamyein.CYTOSTATIC EFFECT OF ADRIAMYCIN IN VITRO










6 lb 2'0 30 40 50 pgm Adriamycin concentration in the medium
FIG. 5.-Correlation of intracellular Adria-
mycin concentration to drug concentration
in the medium. The intracellular drug
concentration was measured fluorimetric-
ally per 2 x 106 Chinese hamster cells after a
2h exposure to the drug.
I _ I
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FiG. 7.-Dependence ofintracellular drugcon-
centration on exposure time to Adriamycin.
The intracellular drug concentration was
measured fluorimetrically per 106 Chinese
hamster cells at an extracellular drug
concentration of 20 ,ug/rnl -0- cells
washed immediately after exposure to
Adriamycin; -*- cells washed for 1 h at
4°C after exposure to Adriamycin.













O0 60 120 180 240 min exposure time
FIG. 6. Dependence of intracellular drug
concentration per 2 x 106 Chinese hamster
cells on exposure times to constant Adria-
mycin concentrations in the medium. The
values are means of 3 experiments with
the standard deviation (where indicated).
in the medium for 2 h at 3700. As shown
in Fig. 5, there is a linear correlation
between intracellular and extracellular
drug concentrations. If the cells were
exposed to a constant drug concentration
with varying exposure times between 30
min and 4 h under the same conditions,
the intracellular drug concentration in-
creased for exposure times up to 2 h, and
then reached a plateau (Fig. 6). If the
cells were washed extensively with Hanks'
solution for 1 h instead of the usual short
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FIG. 8.-Surviving fraction of Chinese ham-
ster cells V8 the absorbed dose of Adria-
mycin. For further details see text.
intracellular drug concentration curve is
shifted to a lower level by about 0 2 ,tg/106
cells (Fig. 7).
DISCUSSION
The results demonstrate that the sur-
viving fraction of both cell lines is an
exponential function of Adriamycin con-
centration in the medium and exposure
time in the range tested (Figs 1-4). The
linear regression gives excellent fits to the
nLool
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experimental data (r2 > 0.90). Skipper et al.
(1970) suggested that the effect of cell-
cycle nonspecific drugs was related to the
product of drug concentration and ex-
posure time. This situation can be de-
scribed by a simple equation:
SF =e-ktc (1)
(SF = surviving fraction of cells; e = basis
of the natural logarithm; k = constant
indicating the sensitivity of cells; t =
duration of exposure in min; c = Adria-
mycin concentration in the medium in
,ug/ml.)
For Chinese hamster and HeLa cells
curves were fitted according to the above
equation, and are presented as dotted
lines in Figs 1 and 2 (constant exposure
times) and Figs 3 and 4 (constant drug
concentrations). The constants were de-
rived from a global least-squares fit of all
logarithmically transformed data at all
exposure times and drug concentrations.
Data in the range of 0 5-0 005 SF were
given double weighting because of their
superior accuracy. The linear regressions
do not differ markedly from the curves
calculated according to the general equa-
tion, although some individual values are
outside the standard deviation.
For Chinese hamster and HeLa cells the
values for the sensitivity constant K are
similar, being 0 05 for HeLa cells, making
them slightly more sensitive to Adriamy-
cin than Chinese hamster cells with K=
0 045.
Exponential survival curves were also
foundforCHO cells (Barranco, etal., 1973),
T1 cells (Drewinko & Gottlieb, 1973) and
EMT6 cells (Twentyman, 1976). However,
at drug concentrations above 2 ,ug/ml
the slopes ofC01O and EMT6 cells decrease
at surviving fractions of less than 0-002,
yielding a biphasic ("hockey stick") curve.
Our method does not allow the accurate
determination of SFs less than 10-3, and
thus a similar biphasic response cannot
be excluded.
The reported CO values of the survival
curves of CHO and T1 cells are about half
those of our Chinese hamster and HeLa
cells. However, different values for C0 do
not necessarily reflect inherent differences
in sensitivity, since incubation tempera-
ture, pH, cell density and age of the cul-
ture influence the in vitro cell sensitivity
(Born & Eichholtz, in preparation).
Wheeler et al. (1978) have demonstrated
that exposure dose, defined as the product
of drug concentration in the medium and
exposure time, is not necessarily the
relevant measure of cytostatic action of
drugs in vitro. We therefore studied
absorbed doses in Chinese hamster cells.
Intracellular concentration of Adriamycin
is not proportional to the product of con-
centration in the medium and exposure
time. At constant exposure time intra-
cellular drug concentration increases pro-
portionally to extracellular druig con-
centration. With increasing exposure
times, however, the intracellular Adri-
amycin concentration did not change
significantly between 2 and 4 h exposure
time. Thus, the surviving fraction, which
appeared to be an exponential function of
exposure dose, is not a simple exponential
function of absorbed dose. Fig. 8 shows
the SF of Chinese hamster cells after
treatment with 1 /tg/ml Adriamycin for
30, 60, 90 and 120 min (as presented in
Fig. 3) plotted against absorbed dose, as
determined by integrating the intracellular
concentration curve in Fig. 6. This survival
curve is neither an exponential nor a
simple power function. Intracellular dose
is more meaningful conceptually but
obviously not "the" biologically active
dose. Interpretation of this curve is not
possible without detailed knowledge of
the micro-distribution ofthe active moiety
in the various intracellular compartments
and the mechanisms by which it kills
mammalian cells.
Since the saturation curve of intra-
cellular drug concentration with graded
exposure times could be due to the
pharmacokinetics of different compart-
ments of uptake and binding, we studied
to what extent Adriamycin could be
washed out of the cells. The drug concen-
tration after 1 h rinsing is probably the
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firmly bound moiety. Its concentration
curve is shifted parallel to the total
concentration curve. Thus, neither the
bound nor the exchangeable compart-
ments will explain the shape of the dose-
response curve of Chinese hamster cells to
increasing exposure times to Adriamycin
in vitro.
I thank Dr K. R. Trott, Dr J. Kummermehr and
Mrs G. Preuss for helpful discussions during the
course of this work. I thank Miss Ingrid Fuhrich for
her excellent technical assistance and Montedison
Farmaceutica, Freiburg, for kindly supplying the
Adriamycin.
REFERENCES
BARRANCO, S. C., GERNER, E. W., BURK, K. H. &
HUMPHREY, R. M. (1973) Survival and cell
kinetics effects ofAdriamycin on mammalian cells.
Cancer Res., 33, 11.
BENJAMIN, R. S., WIERNIK, P. H. & BACHUR, N. R.
(1974) Adriamycin chemotherapy: Efficacy,
safety, and pharmacologic basis ofan intermittent
single high-dosage schedule. Cancer Res., 33, 19.
BORN, R. (1974) Zellkinetische Untersuchungen an
chronisch hypoxischen Fibroblasten des Chinesi-
schen Hamsters. Dissertation, Biologische Fakultdt
der Universitat Muinchen.
CARTER, S. K. (1975) Adriamycin: A review. J. Natl
Cancer Inst., 55, 1265.
CARTER, S. K., Di MARCO, A., GHIONE, M., KRAKOFF,
J. H. & MATHII, G. (1972) InternationalSymposium
on Adriamycin. Berlin: Springer Verlag.
CREASY, W. A., MCINTOSH, L. S., BRESCIA, T. & 4
others (1976) Clinical effects and pharmacokinetics
of different dosage schedules of Adriamycin.
Cancer Re8., 36, 216.
Di MARCO, A. (1975) Adriamycin (NSC-123127)
mode and mechanism of action. Cancer Chemoth.
Rep., 6, 91.
DREWINKO, B. & GOTTLIEB, J. A. (1973) Survival
kinetics of cultured human lymphoma cells
exposed to Adriamycin. Cancer Res., 33, 1141.
EICHHOLTZ, H. & TROTT, K. R. (1980) Effect of
methotrexate concentration and exposure time
on mammalian cell survival in vitro. Br. J.
Cancer, 41, 277.
GOLDIN, A. & JOHNSON, R. K. (1975) Experimental
tumor activity of Adriamycin (NSC-123127).
Cancer Chemoth. Rep., 6, 137.
PACCIARINI, M. A., BARBIERI, B., COLOMBO, T.,
BROGGINI, M., GARATTINI, S. & DONELLI, M. G.
(1978) Distribution and antitumor activity of
Adriamycin given in a high-dose and a repeated
low-dose schedule to mice. Cancer Treat. Rep., 62,
791.
SCHWARTZ, H. S. (1973) A fluorometric assay for
Daunomycin and Adriamycin in animal tissues.
Biochem. Med., 7, 396.
SKIPPER, H. E., SCHABEL, F. M., JR, MELLETT, L. B.
and 4 others (1970) Implications of biochemical,
cytokinetic, pharmacologic and toxicologic rela-
tionships in the design ofoptimal therapeutic sche-
dules. Cancer Chemoth. Rep., 54, 431
TWENTYMAN, P. R. (1976) Comparative chemosensi-
tivity of exponential-ver8us plateau-phase cells
in both in vitro and in vivo model systems. Cancer
Treat. Rep., 60, 1719.
WHEELER, K. T., LEVIN, V. A. & DEEN, D. F. (1978)
Symposium on the principles of radiation research
applied to environmental agents. Radiat. Res., 76,
441.